Sun Pharmaceutical Q3FY23 Results: PAT ₹2166.01 Cr consolidated

Sun Pharmaceutical Q3FY23 Results: PAT ₹2166.01 Cr consolidated

Sun Pharmaceutical Industries Ltd releases Consolidated Financial Results for December 31, 2022.

Financial Results (Q3 FY2023) – Quarter-over-Quarter Comparison:

Total income of Sun Pharmaceutical Industries Ltd is Rs.11414.85 Crores (December 31, 2022) vs. Rs.11037.5 Crores (September 30, 2022)

Net profit/loss: Rs.2166.01 Crores (December 31, 2022) vs. Rs.2262.22 Crores (September 30, 2022)

EPS: Rs.9 (December 31, 2022) vs. Rs.9.4 (September 30, 2022)

FinancialsQ3 FY2023Q2 FY2023% Change
Total Income₹11414.85 Cr₹11037.5 Cr⬆ 3.42%
Net Profit₹2166.01 Cr₹2262.22 Cr⬇ -4.25%
EPS₹9₹9.4⬇ -4.26%

Financial Results (Q3 FY2023) – Year-over-Year Comparison:

Total income of Sun Pharmaceutical Industries Ltd is Rs.11414.85 Crores (December 31, 2022) vs. Rs.10295.57 Crores (December 31, 2022)

Net profit/loss: Rs.2166.01 Crores (December 31, 2022) vs. Rs.2058.80 Crores (December 31, 2022)

EPS: Rs.9 (December 31, 2022) vs. Rs.8.6 (December 31, 2022)

FinancialsQ3 FY2023Q3 FY2022% Change
Total Income₹11414.85 Cr₹10295.57 Cr⬆ 10.87%
Net Profit₹2166.01 Cr₹2058.80 Cr⬆ 5.21%
EPS₹9₹8.6⬆ 4.65%

Financial Results (9 Months Ended FY2023) – Year-over-Year Comparison:

Total income of Sun Pharmaceutical Industries Ltd is Rs.33216.25 Crores (December 31, 2022) vs. Rs.30015.65 Crores (December 31, 2021)

Net profit/loss: Rs.6489.11 Crores (December 31, 2022) vs. Rs.5549.98 Crores (December 31, 2021)

EPS: Rs.27 (December 31, 2022) vs. Rs.23.1 (December 31, 2021)

Financials9 Months Ended FY20239 Months Ended FY2022% Change
Total Income₹33216.25 Cr₹30015.65 Cr⬆ 10.66%
Net Profit₹6489.11 Cr₹5549.98 Cr⬆ 16.92%
EPS₹27₹23.1⬆ 16.88%

For More Latest News Click Here

Leave a Reply

Your email address will not be published. Required fields are marked *